Characterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment

References

• American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS task force. Neurol 1991; 41: 778–785
   PubMed Web of Science ®Google Scholar
• American Academy of Neurology AIDS Task Force. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurol. 1996; 47: 1247–1253
   PubMed Web of Science ®Google Scholar
• Arroyo M A, Tien H, Pagan M, Swanstrom R, Hillyer G V, Cadilla C L, Melendez-Guerrero L M. Virologic risk factors for vertical transmission of HIV type 1 in Puerto Rico. AIDS Res Hum Retroviruses 2002; 18: 447–460
   PubMed Web of Science ®Google Scholar
• Bajetto A, Bonavia R, Barbero S, Piccioli P, Costa A, Florio T, Schettini G. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 1999; 73: 2348–2357
   PubMed Web of Science ®Google Scholar
• Bakri Y, Amzazi S, Mannioui A, Benjouad A. The susceptibility of macrophages to human immunodeficiency virus type 1 X4 isolates depends on their activation state. Biomed Pharmacother 2001; 55: 32–38
   PubMed Web of Science ®Google Scholar
• Bannert N, Schenten D, Craig S, Sodroski J. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses. J Virol 2000; 74: 10984–10993
   PubMed Web of Science ®Google Scholar
• Berger E A, Doms R W, Fenyo E M, Korber B T, Littman D R, Moore J P, Sattentau Q J, Schuitemaker H, Sodroski J, Weiss R A. A new classification for HIV-1. Nature 1998; 391: 240
   PubMed Web of Science ®Google Scholar
• Berger E A, Murphy P M, Farber J M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17: 657–700
   PubMed Web of Science ®Google Scholar
• Burkala E J, He J, West J T, Wood C, Petito C K. Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus. AIDS 2005; 19: 675–684
   PubMed Web of Science ®Google Scholar
• Chang M I, Panorchan P, Dobrowsky T M, Tseng Y, Wirtz D. Single-molecule analysis of human immunodeficiency virus type 1 gp120-receptor interactions in living cells. J Virol 2005; 79: 14748–14755
   PubMed Web of Science ®Google Scholar
• D'Aversa T G, Eugenin E A, Berman J W. NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J Neurosci Res 2005; 81: 436–446
   PubMed Web of Science ®Google Scholar
• Delobel P, Sandres-Saune K, Cazabat M, Pasquier C, Marchou B, Massip P, Izopet J. R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2005; 38: 382–392
   PubMed Web of Science ®Google Scholar
• Di Stefano M, Monno L, Fiore J R, Buccoliero G, Appice A, Perulli L M, Pastore G, Angarano G. Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype. AIDS 1998; 12: 737–743
   PubMed Web of Science ®Google Scholar
• Diesing T S, Swindells S, Gelbard H, Gendelman H E. HIV-1-associated dementia: a basic science and clinical perspective. AIDS Read 2002; 12: 358–368
   PubMedGoogle Scholar
• Dou H, Kingsley J D, Mosley R L, Gelbard H A, Gendelman H E. Neuroprotective strategies for HIV-1 associated dementia. Neurotox Res 2004; 6: 503–521
   PubMed Web of Science ®Google Scholar
• Feige U, Overwien B, Sorg C. Purification of human blood monocytes by hypotonic density gradient centrifugation in Percoll. J Immunol Methods 1982; 54: 309–315
   PubMed Web of Science ®Google Scholar
• Fischer-Smith T, Rappaport J. Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med 2005; 7: 1–26
   PubMedGoogle Scholar
• Galan I, Jimenez J L, Gonzalez-Rivera M, De Jose M I, Navarro M L, Ramos J T, Mellado M J, Gurbindo M D, Bellon J M, Resino S, Cabrero E, Munoz-Fernandez M A. Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected children. AIDS 2004; 18: 247–255
   PubMed Web of Science ®Google Scholar
• Gendelman H E, Anderson E, Meléndez L, Zheng J. Chemokines and their receptors in HIV-1 neuropathogenesis: protection versus injury. Springer, New York 2006
   Google Scholar
• Goodenow M M, Collman R G. HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes. J Leukoc Biol 2006; 80: 965–972
   PubMed Web of Science ®Google Scholar
• Gorry P R, Bristol G, Zack J A, Ritola K, Swanstrom R, Birch C J, Bell J E, Bannert N, Crawford K, Wang H, Schols D, De Clercq E, Kunstman K, Wolinsky S M, Gabuzda D. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 2001; 75: 10073–10089
   PubMed Web of Science ®Google Scholar
• Gorry P R, Sterjovski J, Churchill M, Witlox K, Gray L, Cunningham A, Wesselingh S. The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression. Sex Health 2004; 1: 23–34
   PubMedGoogle Scholar
• Gorry P R, Taylor J, Holm G H, Mehle A, Morgan T, Cayabyab M, Farzan M, Wang H, Bell J E, Kunstman K, Moore J P, Wolinsky S M, Gabuzda D. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol 2002; 76: 6277–6292
   PubMed Web of Science ®Google Scholar
• Gray L, Sterjovski J, Churchill M, Ellery P, Nasr N, Lewin S R, Crowe S M, Wesselingh S L, Cunningham A L, Gorry P R. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology 2005; 337: 384–398
   PubMed Web of Science ®Google Scholar
• Harrington P R, Haas D W, Ritola K, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. J Virol 2005; 79: 7959–7966
   PubMed Web of Science ®Google Scholar
• Hibbitts S, Reeves J D, Simmons G, Gray P W, Epstein L G, Schols D, de Clercq E, Wells T N, Proudfoot A E, Clapham P R. Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1. AIDS Res Hum Retroviruses 1999; 15: 989–1000
   PubMed Web of Science ®Google Scholar
• Huang C C, Tang M, Zhang M Y, Majeed S, Montabana E, Stanfield R L, Dimitrov D S, Korber B, Sodroski J, Wilson I A, Wyatt R, Kwong P D. Structure of a V3-containing HIV-1 gp120 core. Science 2005; 310: 1025–1028
   PubMed Web of Science ®Google Scholar
• Huang Y, Paxton W A, Wolinsky S M, Neumann A U, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau N R, Phair J, Ho D D, Koup R A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2: 1240–1243
   PubMed Web of Science ®Google Scholar
• Johnston E R, Zijenah L S, Mutetwa S, Kantor R, Kittinunvorakoon C, Katzenstein D A. High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J Virol 2003; 77: 7682–7688
   PubMed Web of Science ®Google Scholar
• Jones G, Power C. Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis Jan, 2006; 21(1)1–17, 2005
   PubMed Web of Science ®Google Scholar
• Korber B T, Kunstman K J, Patterson B K, Furtado M, McEvilly M M, Levy R, Wolinsky S M. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994; 68: 7467–7481
   PubMed Web of Science ®Google Scholar
• Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell J E, Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 2005; 111: 194–213
   PubMed Web of Science ®Google Scholar
• Kwa D, Vingerhoed J, Boeser-Nunnink B, Broersen S, Schuitemaker H. Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expression. J Virol 2001; 75: 10455–10459
   PubMed Web of Science ®Google Scholar
• Lathey J L, Brambilla D, Goodenow M M, Nokta M, Rasheed S, Siwak E B, Bremer J W, Huang D D, Yi Y, Reichelderfer P S, Collman R G. Coreceptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?. J Leukoc Biol 2000; 68: 324–330
   PubMed Web of Science ®Google Scholar
• Lee B, Sharron M, Blanpain C, Doranz B J, Vakili J, Setoh P, Berg E, Liu G, Guy H R, Durell S R, Parmentier M, Chang C N, Price K, Tsang M, Doms R W. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem 1999; 274: 9617–9626
   PubMed Web of Science ®Google Scholar
• Mack M, Pfirstinger J, Haas J, Nelson P J, Kufer P, Riethmuller G, Schlondorff D. Preferential targeting of CD4-CCR5 complexes with bifunctional inhibitors: a novel approach to block HIV-1 infection. J Immunol 2005; 175: 7586–7593
   PubMed Web of Science ®Google Scholar
• Marder K, Tang M X, Mejia H, Alfaro B, Cote L, Louis E, Groves J, Mayeux R. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996; 47: 155–160
   PubMed Web of Science ®Google Scholar
• McArthur J C, Sacktor N, Selnes O. Human immunodeficiency virus-associated dementia. Semin Neurol 1999; 19: 129–150
   PubMed Web of Science ®Google Scholar
• Melendez-Guerrero L M, Arroyo M A, Vega M E, Jimenez E, Hillyer G V, Cadilla C L. Characterization of HIV isolates from Puerto Rican maternal-infant pairs reveal predominance of non-syncytium inducing (NSI) variants with CCR5 genotype. Cell Mol Biol (Noisy-le-grand) 2001; 47: OL39–OL47, (published online)
   PubMedGoogle Scholar
• Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 2002; 186: S193–S198, (Suppl 2)
   PubMed Web of Science ®Google Scholar
• Neil S J, Aasa-Chapman M M, Clapham P R, Nibbs R J, McKnight A, Weiss R A. The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes. J Virol 2005; 79: 9618–9624
   PubMed Web of Science ®Google Scholar
• Pillai S K, Kosakovsky Pond S L, Liu Y, Good B M, Strain M C, Ellis R J, Letendre S, Smith D M, Gunthard H F, Grant I, Marcotte T D, Allen McCutchan J, Richman D D, Wong J K. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain Jul, 2006; 129: 1872–1883, 2006 (Pt)
   PubMed Web of Science ®Google Scholar
• Poveda E, Briz V, Quinones-Mateu M, Soriano V. HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS 2006; 20: 1359–1367
   PubMed Web of Science ®Google Scholar
• Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995; 9: 1001–1008
   PubMed Web of Science ®Google Scholar
• Samson M, Libert F, Doranz B J, Rucker J, Liesnard C, Farber C M, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth R J, Collman R G, Doms R W, Vassart G, Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722–725
   PubMed Web of Science ®Google Scholar
• Sharma D, Balamurali M M, Chakraborty K, Kumaran S, Jeganathan S, Rashid U, Ingallinella P, Varadarajan R. Protein minimization of the gp120 binding region of human CD4. Biochemistry 2005; 44: 16192–16202
   PubMedGoogle Scholar
• Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, Watters M, Aguon J, Valcour V. Circulating proviral HIV DNA and HIV-associated dementia. AIDS 2005; 19: 45–52
   PubMed Web of Science ®Google Scholar
• Simmons G, Wilkinson D, Reeves J D, Dittmar M T, Beddows S, Weber J, Carnegie G, Desselberger U, Gray P W, Weiss R A, Clapham P R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996; 70: 8355–8360
   PubMed Web of Science ®Google Scholar
• Sirois S, Sing T, Chou K C. HIV-1 gp120 V3 loop for structure-based drug design. Curr Protein Pept Sci 2005; 6: 413–422
   PubMed Web of Science ®Google Scholar
• Skrabal K, Trouplin V, Labrosse B, Obry V, Damond F, Hance A J, Clavel F, Mammano F. Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations. AIDS 2003; 17: 809–814
   PubMed Web of Science ®Google Scholar
• Spudich S S, Huang W, Nilsson A C, Petropoulos C J, Liegler T J, Whitcomb J M, Price R W. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. J Infect Dis 2005; 191: 890–898
   PubMed Web of Science ®Google Scholar
• Steain M C, Wang B, Dwyer D E, Saksena N K. HIV-1 co-infection, superinfection and recombination. Sex Health 2004; 1: 239–250
   PubMedGoogle Scholar
• Strain M C, Letendre S, Pillai S K, Russell T, Ignacio C C, Gunthard H F, Good B, Smith D M, Wolinsky S M, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman D D, Marcotte T, McCutchan J A, Ellis R J, Wong J K. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 2005; 79: 1772–1788
   PubMed Web of Science ®Google Scholar
• Watabe T, Kishino H, Okuhara Y, Kitazoe Y. Fold recognition of the HIV-1 V3 loop and flexibility of its crown structure during the course of adaptation to a host. Genetics Mar, 2005; 172(3)1385–1396, 2006
   PubMed Web of Science ®Google Scholar
• Weiner R S, Shah V O. Purification of human monocytes: isolation and collection of large numbers of peripheral blood monocytes. J Immunol Methods 1980; 36: 89–97
   PubMed Web of Science ®Google Scholar
• Williams K C, Hickey W F. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 2002; 25: 537–562
   PubMed Web of Science ®Google Scholar
• Wojna V, Carlson K A, Luo X, Mayo R, Melendez L M, Kraiselburd E, Gendelman H E. Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: a case study. J NeuroVirol 2004a; 10: 74–81, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• Wojna V, Skolasky R L, Hechavarria R, Mayo R, Selnes O, McArthur J C, Melendez L M, Maldonado E, Zorrilla C D, Garcia H, Kraiselburd E, Nath A. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J NeuroVirol 2006; 12: 356–364
   PubMed Web of Science ®Google Scholar
• Yi Y, Chen W, Frank I, Cutilli J, Singh A, Starr-Spires L, Sulcove J, Kolson D L, Collman R G. An unusual syncytia-inducing human immunodeficiency virus type 1 primary isolate from the central nervous system that is restricted to CXCR4, replicates efficiently in macrophages, and induces neuronal apoptosis. J NeuroVirol 2003; 9: 432–441
   PubMed Web of Science ®Google Scholar
• Yi Y, Lee C, Liu Q H, Freedman B D, Collman R G. Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis. J NeuroVirol 2004; 10: 91–96, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• Yi Y, Shaheen F, Collman R G. Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes. J Virol 2005; 79: 1480–1486
   PubMed Web of Science ®Google Scholar